These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37641212)

  • 1. TREM2 promotes glioma progression and angiogenesis mediated by microglia/brain macrophages.
    Chen X; Zhao Y; Huang Y; Zhu K; Zeng F; Zhao J; Zhang H; Zhu X; Kettenmann H; Xiang X
    Glia; 2023 Nov; 71(11):2679-2695. PubMed ID: 37641212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of trem2 promotes proinflammatory microglia and inhibits glioma progression via the JAK2/STAT3 and NF-κB pathways.
    Yan Y; Bai S; Han H; Dai J; Niu L; Wang H; Dong Q; Yin H; Yuan G; Pan Y
    Cell Commun Signal; 2024 May; 22(1):272. PubMed ID: 38750472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TREM2 mediates MHCII-associated CD4+ T-cell response against gliomas.
    Zheng J; Wang L; Zhao S; Zhang W; Chang Y; Bosco DB; Huang T; Dheer A; Gao S; Xu S; Ayasoufi K; Al-Kharboosh R; Qi F; Xie M; Johnson AJ; Dong H; Quiñones-Hinojosa A; Wu LJ
    Neuro Oncol; 2024 May; 26(5):811-825. PubMed ID: 37941134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway.
    Zheng H; Jia L; Liu CC; Rong Z; Zhong L; Yang L; Chen XF; Fryer JD; Wang X; Zhang YW; Xu H; Bu G
    J Neurosci; 2017 Feb; 37(7):1772-1784. PubMed ID: 28077724
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Yu M; Chang Y; Zhai Y; Pang B; Wang P; Li G; Jiang T; Zeng F
    Front Immunol; 2022; 13():1089266. PubMed ID: 36713360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triggering receptor expressed on myeloid cells-2 expression in the brain is required for maximal phagocytic activity and improved neurological outcomes following experimental stroke.
    Kurisu K; Zheng Z; Kim JY; Shi J; Kanoke A; Liu J; Hsieh CL; Yenari MA
    J Cereb Blood Flow Metab; 2019 Oct; 39(10):1906-1918. PubMed ID: 30523715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trem2 deficiency impairs recovery and phagocytosis and dysregulates myeloid gene expression during virus-induced demyelination.
    Hwang M; Savarin C; Kim J; Powers J; Towne N; Oh H; Bergmann CC
    J Neuroinflammation; 2022 Nov; 19(1):267. PubMed ID: 36333761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma.
    Sun R; Han R; McCornack C; Khan S; Tabor GT; Chen Y; Hou J; Jiang H; Schoch KM; Mao DD; Cleary R; Yang A; Liu Q; Luo J; Petti A; Miller TM; Ulrich JD; Holtzman DM; Kim AH
    Sci Adv; 2023 May; 9(19):eade3559. PubMed ID: 37172094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury.
    Mazaheri F; Snaidero N; Kleinberger G; Madore C; Daria A; Werner G; Krasemann S; Capell A; Trümbach D; Wurst W; Brunner B; Bultmann S; Tahirovic S; Kerschensteiner M; Misgeld T; Butovsky O; Haass C
    EMBO Rep; 2017 Jul; 18(7):1186-1198. PubMed ID: 28483841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke.
    Kawabori M; Kacimi R; Kauppinen T; Calosing C; Kim JY; Hsieh CL; Nakamura MC; Yenari MA
    J Neurosci; 2015 Feb; 35(8):3384-96. PubMed ID: 25716838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Interacts With Colony-Stimulating Factor 1 Receptor (CSF1R) but Is Not Necessary for CSF1/CSF1R-Mediated Microglial Survival.
    Cheng B; Li X; Dai K; Duan S; Rong Z; Chen Y; Lü L; Liu Z; Huang X; Xu H; Zhang YW; Zheng H
    Front Immunol; 2021; 12():633796. PubMed ID: 33841415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma.
    Peshoff MM; Gupta P; Oberai S; Trivedi R; Katayama H; Chakrapani P; Dang M; Migliozzi S; Gumin J; Kadri DB; Lin JK; Milam NK; Maynard ME; Vaillant BD; Parker-Kerrigan B; Lang FF; Huse JT; Iavarone A; Wang L; Clise-Dwyer K; Bhat KP
    Neuro Oncol; 2024 May; 26(5):826-839. PubMed ID: 38237157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of TREM2 Confers Resilience to Synaptic and Cognitive Impairment in Aged Mice.
    Qu W; Li L
    J Neurosci; 2020 Dec; 40(50):9552-9563. PubMed ID: 33139402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease.
    Jay TR; Hirsch AM; Broihier ML; Miller CM; Neilson LE; Ransohoff RM; Lamb BT; Landreth GE
    J Neurosci; 2017 Jan; 37(3):637-647. PubMed ID: 28100745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of TREM2 enhances glioma cell proliferation and invasion: a therapeutic target in human glioma.
    Wang XQ; Tao BB; Li B; Wang XH; Zhang WC; Wan L; Hua XM; Li ST
    Oncotarget; 2016 Jan; 7(3):2354-66. PubMed ID: 26506595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge.
    Nugent AA; Lin K; van Lengerich B; Lianoglou S; Przybyla L; Davis SS; Llapashtica C; Wang J; Kim DJ; Xia D; Lucas A; Baskaran S; Haddick PCG; Lenser M; Earr TK; Shi J; Dugas JC; Andreone BJ; Logan T; Solanoy HO; Chen H; Srivastava A; Poda SB; Sanchez PE; Watts RJ; Sandmann T; Astarita G; Lewcock JW; Monroe KM; Di Paolo G
    Neuron; 2020 Mar; 105(5):837-854.e9. PubMed ID: 31902528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TREM2 overexpression rescues cognitive deficits in APP/PS1 transgenic mice by reducing neuroinflammation via the JAK/STAT/SOCS signaling pathway.
    Ruganzu JB; Zheng Q; Wu X; He Y; Peng X; Jin H; Zhou J; Ma R; Ji S; Ma Y; Qian Y; Wang Y; Yang W
    Exp Neurol; 2021 Feb; 336():113506. PubMed ID: 33065077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's Risk Gene TREM2 Determines Functional Properties of New Type of Human iPSC-Derived Microglia.
    Reich M; Paris I; Ebeling M; Dahm N; Schweitzer C; Reinhardt D; Schmucki R; Prasad M; Köchl F; Leist M; Cowley SA; Zhang JD; Patsch C; Gutbier S; Britschgi M
    Front Immunol; 2020; 11():617860. PubMed ID: 33613545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer's disease.
    Claes C; Danhash EP; Hasselmann J; Chadarevian JP; Shabestari SK; England WE; Lim TE; Hidalgo JLS; Spitale RC; Davtyan H; Blurton-Jones M
    Mol Neurodegener; 2021 Jul; 16(1):50. PubMed ID: 34301296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease.
    Melchior B; Garcia AE; Hsiung BK; Lo KM; Doose JM; Thrash JC; Stalder AK; Staufenbiel M; Neumann H; Carson MJ
    ASN Neuro; 2010 Jul; 2(3):e00037. PubMed ID: 20640189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.